Your browser doesn't support javascript.
loading
Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide and dexamethasone (Rd) in the phase III ASPIRE study.
Dimopoulos, Meletios; Wang, Michael; Maisnar, Vladimir; Minarik, Jiri; Bensinger, William; Mateos, Maria-Victoria; Obreja, Mihaela; Blaedel, Julie; Moreau, Philippe.
Afiliação
  • Dimopoulos M; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. mdimop@med.uoa.gr.
  • Wang M; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maisnar V; Faculty Hospital and Medical Faculty of Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Minarik J; University Hospital Olomouc, Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic.
  • Bensinger W; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Mateos MV; Hospital Clinico Universitario de Salamanca-IBSAL, Salamanca, Spain.
  • Obreja M; Amgen, Inc., Thousand Oaks, CA, USA.
  • Blaedel J; Amgen, Inc., Thousand Oaks, CA, USA.
  • Moreau P; University of Nantes, Nantes, France.
J Hematol Oncol ; 11(1): 49, 2018 04 04.
Article em En | MEDLINE | ID: mdl-29615082
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article